Novation members including VHA, UHC and Provista will have access to Cook’s CVC product including Spectrum minocycline and rifampin impregnated catheters from 1 January 2012.

Cook Medical Critical Care and Interventional Radiology divisions vice president and business unit leader Dan Sirota said their Spectrum central venous catheter sets have been shown to minimize the risk of catheter-related bloodstream infections (CRBSIs).

"Cook is proud to partner with Novation in delivering a technology that helps prevent dangerous and potentially fatal infections and reduces health care costs to its expansive network of health care providers," Sirota said.